FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139329867> ?p ?o ?g. }

• W2139329867 endingPage "240" @default.
• W2139329867 startingPage "234" @default.
• W2139329867 abstract "Aims and background There has been a trend to replace cisplatin with carboplatin in the treatment of small-cell lung carcinoma. The goal of the present study was to determine the efficacy of carboplatin and etoposide followed by thoracic radiotherapy in patients with previously untreated limited disease small-cell lung carcinoma. Methods From February 2001 to March 2007, 47 patients with limited disease small-cell lung cancer were enrolled in the study. Etoposide, 100 mg/m2, was administrated intravenously on days 1-3 in combination with carboplatin, AUC 6, on day 1 every 21 days for 6 cycles. In cases considered to have non-progressive disease following induction chemotherapy, thoracic radiotherapy was given with in a once daily fraction of 2.0 Gy, 5/wk, up to 50-60 Gy. Results Forty-one patients were evaluated. Median age was 62 (range, 40-78), 88% of patients were male. ECOG PS was 0-1 in 38 patients. Seven of the 41 patients (17.5%) had pleural effusion (one malignant) and 7 patients (17.5%) had involved supraclavicular lymph nodes. Ninety percent of patients had elevated serum lactate dehydrogenase levels. Median follow-up was 13.5 mo. A total of 209 cycles of chemotherapy was administered (median, 6; range, 1-6). Thoracic irradiation was given to 33 patients. The overall response rate to combined modality on an intention-to-treat basis was 73%. Median survival time was 13.7 months (95% CI, 10.3-17.1), and median progression-free survival was 9.5 months (95% CI, 8.6-10.4). Two- and four-year overall survival was 23% and 7%, respectively. Grade 3-4 neutropenia and leukopenia were the most common adverse events and occurred in 46.0% and 24.0% of the patients, respectively. Six (14%) patients experienced febrile neutropenia. Three patients (7%) died of sepsis and neutropenic fever. Non-hematological toxicities were mild. Conclusions Carboplatin and etoposide chemotherapy followed by thoracic radiotherapy in LD-SCLC appears to be unsatisfactory." @default.
• W2139329867 created "2016-06-24" @default.
• W2139329867 creator A5006391790 @default.
• W2139329867 creator A5010916498 @default.
• W2139329867 creator A5011969758 @default.
• W2139329867 creator A5046730524 @default.
• W2139329867 creator A5059207168 @default.
• W2139329867 creator A5071339363 @default.
• W2139329867 date "2010-03-01" @default.
• W2139329867 modified "2023-09-23" @default.
• W2139329867 title "Carboplatin and etoposide followed by once-daily thoracic radiotherapy in limited disease small-cell lung cancer: unsatisfactory results." @default.
• W2139329867 cites W1481967818 @default.
• W2139329867 cites W1903188031 @default.
• W2139329867 cites W1905406155 @default.
• W2139329867 cites W1951792712 @default.
• W2139329867 cites W1973510243 @default.
• W2139329867 cites W1997456772 @default.
• W2139329867 cites W2008040218 @default.
• W2139329867 cites W2031170553 @default.
• W2139329867 cites W2062342368 @default.
• W2139329867 cites W2074552727 @default.
• W2139329867 cites W2083817990 @default.
• W2139329867 cites W2084090520 @default.
• W2139329867 cites W2120277401 @default.
• W2139329867 cites W2124353451 @default.
• W2139329867 cites W2125430981 @default.
• W2139329867 cites W2145351799 @default.
• W2139329867 cites W2150713507 @default.
• W2139329867 cites W2160012348 @default.
• W2139329867 cites W2162629228 @default.
• W2139329867 cites W2167805334 @default.
• W2139329867 cites W2216166526 @default.
• W2139329867 cites W2323020638 @default.
• W2139329867 cites W2341745217 @default.
• W2139329867 doi "https://doi.org/10.1700/488.5772" @default.
• W2139329867 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20572579" @default.
• W2139329867 hasPublicationYear "2010" @default.
• W2139329867 type Work @default.
• W2139329867 sameAs 2139329867 @default.
• W2139329867 citedByCount "1" @default.
• W2139329867 countsByYear W21393298672022 @default.
• W2139329867 crossrefType "journal-article" @default.
• W2139329867 hasAuthorship W2139329867A5006391790 @default.
• W2139329867 hasAuthorship W2139329867A5010916498 @default.
• W2139329867 hasAuthorship W2139329867A5011969758 @default.
• W2139329867 hasAuthorship W2139329867A5046730524 @default.
• W2139329867 hasAuthorship W2139329867A5059207168 @default.
• W2139329867 hasAuthorship W2139329867A5071339363 @default.
• W2139329867 hasConcept C121608353 @default.
• W2139329867 hasConcept C126322002 @default.
• W2139329867 hasConcept C141071460 @default.
• W2139329867 hasConcept C2776232967 @default.
• W2139329867 hasConcept C2776256026 @default.
• W2139329867 hasConcept C2776694085 @default.
• W2139329867 hasConcept C2778119113 @default.
• W2139329867 hasConcept C2778239845 @default.
• W2139329867 hasConcept C2778822529 @default.
• W2139329867 hasConcept C2779013556 @default.
• W2139329867 hasConcept C2779223589 @default.
• W2139329867 hasConcept C2779292878 @default.
• W2139329867 hasConcept C2779562246 @default.
• W2139329867 hasConcept C2779634585 @default.
• W2139329867 hasConcept C2781451048 @default.
• W2139329867 hasConcept C45393284 @default.
• W2139329867 hasConcept C500558357 @default.
• W2139329867 hasConcept C509974204 @default.
• W2139329867 hasConcept C71924100 @default.
• W2139329867 hasConcept C90924648 @default.
• W2139329867 hasConceptScore W2139329867C121608353 @default.
• W2139329867 hasConceptScore W2139329867C126322002 @default.
• W2139329867 hasConceptScore W2139329867C141071460 @default.
• W2139329867 hasConceptScore W2139329867C2776232967 @default.
• W2139329867 hasConceptScore W2139329867C2776256026 @default.
• W2139329867 hasConceptScore W2139329867C2776694085 @default.
• W2139329867 hasConceptScore W2139329867C2778119113 @default.
• W2139329867 hasConceptScore W2139329867C2778239845 @default.
• W2139329867 hasConceptScore W2139329867C2778822529 @default.
• W2139329867 hasConceptScore W2139329867C2779013556 @default.
• W2139329867 hasConceptScore W2139329867C2779223589 @default.
• W2139329867 hasConceptScore W2139329867C2779292878 @default.
• W2139329867 hasConceptScore W2139329867C2779562246 @default.
• W2139329867 hasConceptScore W2139329867C2779634585 @default.
• W2139329867 hasConceptScore W2139329867C2781451048 @default.
• W2139329867 hasConceptScore W2139329867C45393284 @default.
• W2139329867 hasConceptScore W2139329867C500558357 @default.
• W2139329867 hasConceptScore W2139329867C509974204 @default.
• W2139329867 hasConceptScore W2139329867C71924100 @default.
• W2139329867 hasConceptScore W2139329867C90924648 @default.
• W2139329867 hasIssue "2" @default.
• W2139329867 hasLocation W21393298671 @default.
• W2139329867 hasOpenAccess W2139329867 @default.
• W2139329867 hasPrimaryLocation W21393298671 @default.
• W2139329867 hasVolume "96" @default.
• W2139329867 isParatext "false" @default.
• W2139329867 isRetracted "false" @default.
• W2139329867 magId "2139329867" @default.
• W2139329867 workType "article" @default.